RAD001 (Everolimus)
Drug timelines are a Plus or Pro feature.
16 regulatory and trial events tracked for RAD001 (Everolimus), covering 2009-01-21 to 2026-07-30. Get the full timeline:
Most recent: Clinical Trial Results: A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma [Phase 2]